Skip to main content
Full access
CLINICAL SYNTHESIS
Published Online: 1 July 2011

Ask the Expert: Anxiety Disorders Virtual Reality Therapy

I have a patient who has a debilitating fear of flying and who heard about virtual reality exposure therapy. Can you tell me more about this type of therapy and what I can advise her to expect?
Virtual reality (VR) is a multimedia computer interaction in which users are active participants within a computer-generated three-dimensional virtual world. Virtual environments differ from traditional computer displays in that the user experiences a sense of presence or immersion in the virtual environment. We consider this presence important for exposure therapy. VR exposure (VRE) is intended to be a component of a comprehensive treatment package and is recommended at the point in therapy when exposure therapy would be introduced.
The most common approach is for the user to wear a head-mounted display. Head-mounted displays are like helmets with separate mini-TV screens for each eye, earphones, and a head-tracking device. This technology integrates real-time computer graphics, body tracking devices, visual displays, and other sensory input devices to immerse a participant in a computer-generated virtual environment that changes in a natural way with head and body motion. For some environments, users may also hold a second position sensor or joystick in their hands that allows them to manipulate or move around the virtual environment, for example, to use a virtual hand to push an elevator button and ascend or to move a Humvee down a desert highway.
Exposure therapy is the treatment of choice for many of the anxiety disorders, especially when avoidance is a prominent symptom. Approximately one-half of patients with a fear of flying (FOF) meet the criteria for panic disorder and about one-half meet criteria for specific phobia, all of whom have been shown to respond to VRE therapy (1, 2). Two randomized clinical trials have been published comparing VR to in vivo exposure for the FOF (1, 2) and indicated that VRE was as effective as standard in vivo exposure. Follow-up data indicate that treatment gains were maintained at 6 and 12 months posttreatment. VRE has the advantages of conducting time-consuming exposure therapy without leaving the therapist's office and offering more control over exposure stimuli and less exposure of the patient to possible harm or embarrassment. For the FOF, for example, airplane “trips” can be conducted by VRE without leaving the therapist's office, and the appropriate stimuli presented. If the patient is not ready for turbulence, we can guarantee no turbulence but can introduce it at the appropriate point in therapy. The therapist can see on the computer monitor what the patient views in the head-mounted display and therefore can comment appropriately and encourage continued exposure until anxiety decreases. For virtual environments such as the Virtual Iraq with loud audio stimuli (e.g., explosions and gunfire), the therapist communicates with the patient with a microphone heard over the earphones. Some environments also include vibrations and odors delivered at the appropriate points in the scenes. For the FOF, the patient can feel the vibrations of the airplane engine and turbulence from a speaker mounted in the raised platform underneath the chair.
In the first published controlled study applying VR to the treatment of a psychiatric disorder, VRE was incorporated in the treatment of acrophobia (fear of heights) (3). Participants were repeatedly exposed to virtual foot bridges of varying heights and stability, outdoor balconies of varying heights, and a glass elevator that ascended 50 floors. VRE was effective in significantly reducing fear of and improving attitudes toward heights, whereas no change was noted in the control group. More importantly, 7 of the 10 VRE treatment completers exposed themselves to real-life height situations by the end of treatment although they were not instructed to do so.
VRE has been applied to several anxiety disorders, substance use disorders, and speech fluency disorders. A growing body of literature supports the use of VRE as a tool for exposure therapy within a comprehensive treatment program (4), with two meta-analyses indicating large effect sizes (5, 6). Several case studies or open clinical trials support the use of VR in the treatment of anxiety disorders, including posttraumatic stress disorder, FOF, fear of public speaking, specific phobia of spiders, and claustrophobia.

REFERENCES

1.
Rothbaum BO, Hodges L, Smith S, Lee JH, Price L: A controlled study of virtual reality exposure therapy for the fear of flying. J Consult Clin Psychol 2000; 68:1020–1026
2.
Rothbaum BO, Hodges L, Anderson P, Zimand E, Lang D, Wilson J: Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying. Behav Ther 2006; 37:80–90
3.
Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford J, North MM: Effectiveness of virtual reality graded exposure in the treatment of acrophobia. Am J Psychiatry 1995; 152:626–628
4.
Rothbaum B: Virtual reality exposure therapy, in The Nature and Treatment of Pathological Anxiety. Edited by Rothbaum BO. New York, Guilford, 2006, pp 227–244
5.
Parsons TD, Rizzo AA: Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: a meta-analysis. J Behav Ther Exp Psychiatry 2008; 39:250–261
6.
Powers MB, Emmelkamp PM: Virtual reality exposure therapy for anxiety disorders: a meta-analysis. J Anxiety Disord 2008; 22:561–569

Information & Authors

Information

Published In

History

Published online: 1 July 2011
Published in print: Summer 2011

Authors

Details

Barbara O. Rothbaum, Ph.D., A.B.P.P. [email protected]

Notes

Address correspondence to Barbara O. Rothbaum, Ph.D., A.B.P.P., Professor in Psychiatry, Director, Trauma and Anxiety Recovery Program, Emory University School of Medicine, 1256 Briarcliff Road, Atlanta, GA 30306; email: [email protected]

Funding Information

CME Disclosure
Barbara O. Rothbaum, Ph.D., A.B.P.P., Professor in Psychiatry, and Director, Trauma and Anxiety Recovery Program, Emory University School of Medicine, Atlanta, GA
Dr. Rothbaum and Emory University own equity in Virtually Better, Inc., which is developing products related to the virtual reality research described in this paper, and Dr. Rothbaum is a consultant for Virtually Better, Inc. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share